These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 8725006

  • 1. Production, analysis and bioactivity of recombinant vasoactive intestinal peptide analogs.
    Raingeaud J, Lavergne F, Lelievre V, Muller JM, Julien R, Cenatiempo Y.
    Biochimie; 1996; 78(1):14-25. PubMed ID: 8725006
    [Abstract] [Full Text] [Related]

  • 2. An improved method to obtain a single recombinant vasoactive intestinal peptide (VIP) analog.
    Ottavi A, Tiennault E, Maftah A, Berjeaud JM, Cenatiempo Y, Julien R.
    Biochimie; 1998 Apr; 80(4):289-93. PubMed ID: 9672747
    [Abstract] [Full Text] [Related]

  • 3. A new vasoactive intestinal peptide antagonist discriminates VIP receptors on guinea pig trachea and human neuroblastoma cells.
    Leroux F, Goossens JF, Pommery N, Hénichart JP.
    Regul Pept; 1994 Jul 14; 52(2):119-28. PubMed ID: 7972935
    [Abstract] [Full Text] [Related]

  • 4. Synthesis, cloning and expression in Escherichia coli of artificial genes coding for biologically active elongated precursors of the vasoactive intestinal polypeptide.
    Simoncsits A, Tjörnhammar ML, Kalman M, Cserpan I, Gafvelin G, Bartfai T.
    Eur J Biochem; 1988 Dec 15; 178(2):343-50. PubMed ID: 3145201
    [Abstract] [Full Text] [Related]

  • 5. Identification of a VIP-specific receptor in guinea pig tenia coli.
    Teng BQ, Grider JR, Murthy KS.
    Am J Physiol Gastrointest Liver Physiol; 2001 Sep 15; 281(3):G718-25. PubMed ID: 11518684
    [Abstract] [Full Text] [Related]

  • 6. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
    Zawilska JB, Dejda A, Niewiadomski P, Gozes I, Nowak JZ.
    J Mol Neurosci; 2005 Sep 15; 25(3):215-24. PubMed ID: 15800375
    [Abstract] [Full Text] [Related]

  • 7. Vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide receptor chimeras reveal domains that determine specificity of vasoactive intestinal polypeptide binding and activation.
    Hashimoto H, Ogawa N, Hagihara N, Yamamoto K, Imanishi K, Nogi H, Nishino A, Fujita T, Matsuda T, Nagata S, Baba A.
    Mol Pharmacol; 1997 Jul 15; 52(1):128-35. PubMed ID: 9224822
    [Abstract] [Full Text] [Related]

  • 8. Structure-activity studies of vasoactive intestinal peptide (VIP): cyclic disulfide analogs.
    Bolin DR, Cottrell J, Garippa R, O'Neill N, Simko B, O'Donnell M.
    Int J Pept Protein Res; 1993 Feb 15; 41(2):124-32. PubMed ID: 8384606
    [Abstract] [Full Text] [Related]

  • 9. The long-acting vasoactive intestinal polypeptide agonist RO 25-1553 is highly selective of the VIP2 receptor subclass.
    Gourlet P, Vertongen P, Vandermeers A, Vandermeers-Piret MC, Rathe J, De Neef P, Waelbroeck M, Robberecht P.
    Peptides; 1997 Feb 15; 18(3):403-8. PubMed ID: 9145428
    [Abstract] [Full Text] [Related]

  • 10. Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide1, and chimeric amino-terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide1 receptors: evidence for multiple receptor states.
    Van Rampelbergh J, Gourlet P, De Neef P, Robberecht P, Waelbroeck M.
    Mol Pharmacol; 1996 Dec 15; 50(6):1596-604. PubMed ID: 8967982
    [Abstract] [Full Text] [Related]

  • 11. Dual actions of S-nitrosylated derivative of vasoactive intestinal peptide as a vasoactive intestinal peptide-like mediator and a nitric oxide carrier.
    Jia L, Stamler JS.
    Eur J Pharmacol; 1999 Jan 29; 366(1):79-86. PubMed ID: 10064155
    [Abstract] [Full Text] [Related]

  • 12. Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP.
    Lutz EM, Ronaldson E, Shaw P, Johnson MS, Holland PJ, Mitchell R.
    Mol Cell Neurosci; 2006 Feb 29; 31(2):193-209. PubMed ID: 16226889
    [Abstract] [Full Text] [Related]

  • 13. Antagonistic actions of analogs related to growth hormone-releasing hormone (GHRH) on receptors for GHRH and vasoactive intestinal peptide on rat pituitary and pineal cells in vitro.
    Rekasi Z, Varga JL, Schally AV, Halmos G, Groot K, Czompoly T.
    Proc Natl Acad Sci U S A; 2000 Feb 01; 97(3):1218-23. PubMed ID: 10655511
    [Abstract] [Full Text] [Related]

  • 14. Alanine scanning of VIP. Structure-function relationship for binding to human recombinant VPAC1 receptor.
    Nicole P, Rouyer-Fessard C, Couvineau A, Drouot C, Fulcrand P, Martinez J, Laburthe M.
    Ann N Y Acad Sci; 2000 Feb 01; 921():352-6. PubMed ID: 11193851
    [No Abstract] [Full Text] [Related]

  • 15. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D, Anouar Y, Jegou S, Fournier A, Vaudry H.
    Endocrinology; 1999 Mar 01; 140(3):1285-93. PubMed ID: 10067855
    [Abstract] [Full Text] [Related]

  • 16. Different vasoactive intestinal polypeptide receptor domains are involved in the selective recognition of two VPAC(2)-selective ligands.
    Juarranz MG, Van Rampelbergh J, Gourlet P, De Neef P, Cnudde J, Robberecht P, Waelbroeck M.
    Mol Pharmacol; 1999 Dec 01; 56(6):1280-7. PubMed ID: 10570056
    [Abstract] [Full Text] [Related]

  • 17. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
    Solano RM, Carmena MJ, Carrero I, Cavallaro S, Roman F, Hueso C, Travali S, Lopez-Fraile N, Guijarro LG, Prieto JC.
    Endocrinology; 1996 Jul 01; 137(7):2815-22. PubMed ID: 8770902
    [Abstract] [Full Text] [Related]

  • 18. Parathyroid hormone (PTH) and PTH-related peptide induce relaxation of smooth muscle cells from guinea pig ileum: interaction with vasoactive intestinal peptide receptors.
    Botella A, Rekik M, Delvaux M, Davicco MJ, Barlet JP, Frexinos J, Bueno L.
    Endocrinology; 1994 Nov 01; 135(5):2160-7. PubMed ID: 7525262
    [Abstract] [Full Text] [Related]

  • 19. Analogues of VIP, helodermin, and PACAP discriminate between rat and human VIP1 and VIP2 receptors.
    Gourlet P, Vandermeers A, Van Rampelbergh J, De Neef P, Cnudde J, Waelbroeck M, Robberecht P.
    Ann N Y Acad Sci; 1998 Dec 11; 865():247-52. PubMed ID: 9928018
    [Abstract] [Full Text] [Related]

  • 20. Design, Recombinant Fusion Expression and Biological Evaluation of Vasoactive Intestinal Peptide Analogue as Novel Antimicrobial Agent.
    Xu C, Guo Y, Qiao X, Shang X, Niu W, Jin M.
    Molecules; 2017 Nov 14; 22(11):. PubMed ID: 29135962
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.